CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

11 فبراير 2025 11:15:22 بحسب NetDania Notify

Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU

11 فبراير 2025 07:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 فبراير 2025 09:45:04 بحسب NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

29 يناير 2025 14:22:37 بحسب NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

28 يناير 2025 12:08:45 بحسب NetDania Notify

Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference

28 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

27 يناير 2025 11:55:04 بحسب NetDania Notify

Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025

08 يناير 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 يناير 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors

09 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

03 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference

21 نوفمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

12 نوفمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update

07 نوفمبر 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024

04 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference

29 أكتوبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)

16 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit

26 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference

05 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung

20 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire